The Latest Breaking News from HUM

The stock market will likely stay under pressure this year, with stubborn inflation and elevated interest rates. However, the Fed’s decision could largely be influenced by concerns about the recent banking crisis. Amid such uncertainty, fundamentally sound stocks Johnson & Johnson (JNJ), Abbott Laboratories (ABT), and Humana (HUM) could be…

Investor sentiment has been significantly affected due to the recent bank failures and concerns over the Fed’s forthcoming rate hike. With the end to the current market volatility not in sight, investors may consider buying fundamentally strong stocks, The Coca-Cola Company (KO), Oracle (ORCL), Humana (HUM), and Gartner (IT), to…

As the Fed is expected to raise interest rates higher than expected, the revived recession fears will keep the stock market under pressure in the upcoming months. Thus, it could be wise to scoop up shares of high-quality businesses, such as Johnson & Johnson (JNJ), Humana Inc. (HUM), and AutoZone,…

Amid concerns that sticky inflation might lead to more rate hikes, the stock market is expected to remain volatile in the near term. So, investors should focus on their long-term strategy and scoop up quality stocks McDonald's (MCD), Verizon (VZ), Salesforce (CRM), Humana (HUM), and STMicroelectronics (STM), which look poised…

Humana earnings topped Q4 estimates. The top-rated managed care stock gave positive 2023 guidance. HUM stock flirted with a buy signal.

With expanding medical needs and technological advancements, the healthcare industry’s prospects look impressive. Moreover, healthcare stocks tend to perform relatively well, irrespective of economic conditions, thanks to the inelastic demand for their products and services. Therefore, we think Nature’s Sunshine Products (NATR), Abbott Laboratories (ABT), Humana (HUM), Molina Healthcare (MOH),…

With economic growth moderating just enough to keep hopes of a Fed-engineered ‘soft landing’ alive, shares of fundamentally strong, resilient, and growing businesses AT&T (T), Amgen (AMGN), Humana (HUM) could be worth investing in for sustained risk-adjusted returns. Continue reading….

The healthcare industry usually holds up well in times of uncertainty, thanks to the inelastic demand for their products and services. As macroeconomic uncertainties related to the high inflation and a potential recession remain, quality stocks Humana (HUM), NextGen Healthcare (NXGN), and InfuSystem (INFU) might be ideal buys now. Keep…

The Fed expected to continue with its rate hikes, and looming recession fears should keep the market under pressure in the near term. Amid widespread volatility, investors could consider buying quality dividend-paying stocks Procter & Gamble (PG) and Humana (HUM). Keep reading….

With the Fed signaling to keep raising rates through this year, the threat of a recession is looming. Given an uncertain market backdrop, investors should buy fundamentally sound stocks, PepsiCo (PEP), Humana (HUM), and Sysco Corp. (SYY), that can generate steady returns. Read on….

The healthcare industry is poised to witness robust growth in the near term due to rising global medical requirements. Also, because the healthcare sector tends to hold up relatively well during economic uncertainties, investors could add quality healthcare stocks UnitedHealth Group (UNH) and Humana (HUM) to their portfolio now. Read…